Overview
Mentions in press and media 21
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 12, 2026 | Nature Medicine Study Shows AI Outperforms Therapists on Cognitive Behavioral Therapy | Limbic, the leading evidence-based clinical mental health AI company, today announced the publication of a randomized, double-blind study in Nature Medicine evaluating its clinical reasoning system that enables AI therapy agents to deliver ... |
| Nov 20, 2025 | Overture Life Receives CE Mark Approval to Commercialize Fertility Automation in Europe | Overture Life, the global leader in automated IVF and the first company to achieve live births from both robotic fertilization and robotic egg freezing, announced that the company has secured CE Mark certification for its DaVitri platform t... |
| Nov 17, 2025 | Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization | Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced the appointment of new leadership to drive the commercialization of its INDUCE-seq® platform, now available to cell and gene therapy dev... |
| Sep 22, 2022 | Memorial Sloan Kettering researchers present predictive findings from first use of Mission Bio's scMRD assay for AML | With early access to Mission Bio's novel Single-cell Multi-omics Measurable Residual Disease (scMRD) assay for AML, MSK researchers identified clonal architecture with the potential to better predict patient relapse Preliminary data shared ... |
| Apr 19, 2022 | Mission Bio Partners with S2 Genomics to Offer Robust Solid Tumor Sample Prep for Single-Cell DNA Analysis | MSKCC lab paired Tapestri and Singulator 100 to demonstrate automated nuclei extraction workflow for fast and reliable nuclei prep for single-cell DNA analysis SOUTH SAN FRANCISCO, Calif., April 19, 2022 /PRNewswire/ -- Mission Bio, Inc., t... |
| Dec 14, 2021 | Cellares Finishes Year of Strong Growth With Key Hires | SOUTH SAN FRANCISCO, Calif., Dec. 14, 2021 /PRNewswire/ -- Cellares Corporation, a life sciences technology company pioneering a revolutionary automated approach to cell therapy manufacturing, today announced several new additions to its le... |
| Sep 16, 2021 | Rune Labs : Raises $22.8 Million Series A Financing to Support the Expansion of Brain Data Software Platform | SAN FRANCISCO, Sept. 16, 2021 /PRNewswire/ -- Rune Labs, a brain data company empowering the development and delivery of precision neuroscience therapeutics, today announced a $22.8 million Series A financing. The round was led by Eclipse V... |
| Aug 24, 2021 | SOPHiA GENETICS : Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Latin America | SÃO PAULO, Brazil and BOSTON, Aug. 24, 2021 /PRNewswire/ -- Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to offer the first decentralized HRD (Ho... |
| Jul 3, 2021 | SOPHiA GENETICS : Announces Filing of Registration Statement for Proposed Initial Public Offering | BOSTON and LAUSANNE, Switzerland, July 2, 2021 /PRNewswire/ -- SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today that it has filed a registration stat... |
Reviews 0
FAQ about Consort Partners PR
When was Consort Partners PR founded?
Consort Partners PR was founded in 2004.
What has the press written about Consort Partners PR?
Parsers VC has collected 21 articles mentioning Consort Partners PR, among them “Nature Medicine Study Shows AI Outperforms Therapists on Cognitive Behavioral Therapy” (Mar 12, 2026) and “Overture Life Receives CE Mark Approval to Commercialize Fertility Automation in Europe” (Nov 20, 2025).
Is Consort Partners PR still active?
Yes, Consort Partners PR is active; its latest activity on Parsers VC dates from Jun 25, 2026.